Antibody neutralizing human respiratory syncytial virus
View Patent ↗The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.
1. An isolated nucleic acid molecule encoding an antibody heavy chain variable region comprising the amino acid sequence of SEQ ID NO:7, an antibody light chain variable region comprising the amino acid sequence of SEQ ID NO:8, or encoding both an antibody heavy chain variable region comprising the amino acid sequence of SEQ ID NO:7 and an antibody light chain variable region comprising the amino acid sequence of SEQ ID NO:8.
2. The isolated nucleic acid molecule of claim 1 , wherein the isolated nucleic acid molecule encodes an antibody heavy chain comprising the amino acid sequence of SEQ ID NO:23, an antibody light chain comprising the amino acid sequence of SEQ ID NO:25, or encoding both an antibody heavy chain comprising the amino acid sequence of SEQ ID NO:23 and an antibody light chain comprising the amino acid sequence of SEQ ID NO:25.
3. The isolated nucleic acid molecule of claim 2 , wherein the nucleic acid molecule encoding the antibody heavy chain has the nucleic acid sequence set forth in SEQ ID NO:24 and the nucleic acid molecule encoding the antibody light chain has the nucleic acid sequence set forth in SEQ ID NO:26.
4. An isolated nucleic acid molecule comprising a nucleic acid sequence set forth in SEQ ID NO:17.
5. An expression vector comprising the nucleic acid molecule of claim 1 , 2 , 3 or 4 .
6. A host cell comprising the expression vector of claim 5 .
7. The host cell of claim 6 , wherein the host cell is a Pichia cell or a Chinese hamster ovary cell.